Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation

Ameenathul M. Fawzy; Brian Olshansky; Professor Gregory Lip

doi:10.1016/j.ahj.2018.10.003

Related publications

Article2019

Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation

Jurriën M. ten Berg, Anne de Veer, Jonas Oldgren, Philippe Gabríel Steg, D. A. Zateyshchikov, Petr Janský, Ki‐Bae Seung, Stefan H. Hohnloser, Professor Gregory Lip, Matias Nordaby, Eva Kleine, Deepak L. Bhatt, Christopher P. Cannon

Article2018

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2022

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy

Mette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, Jesper Smit, Michael Dalager‐Pedersen, Torben Bjerregaard Larsen, Professor Gregory Lip

Article2021

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation

P. H. Kevin Chang, Wei‐Ting Wang, Yi‐Wen Tsai, Hao‐Min Cheng, Wei-Lun Wu, Hui‐Chin Chang, Chen‐Huan Chen, Shih‐Hwa Chiou, Professor Gregory Lip, Chern‐En Chiang

Article2016

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Raphaël Philippart, Anne Brunet-Bernard, Nicolas Clémenty, Thierry Bourguignon, Alain Mirza, Denis Angoulvant, Dominique Babuty, Professor Gregory Lip, Laurent Fauchier